...
首页> 外文期刊>Journal of Epidemiology & Community Health >Risk of overdose and death following codeine prescription among immigrants
【24h】

Risk of overdose and death following codeine prescription among immigrants

机译:在移民中服用可待因处方后服药过量和死亡的风险

获取原文
获取原文并翻译 | 示例

摘要

Background Immigrants may be at a higher risk of adverse drug reactions, in that poor language proficiency reduces individuals understanding of drug label instructions. Additionally, there are reports of severe or fatal toxicity due to CYP2D6 ultrarapid hepatic metabolism of codeine to morphine among some ethnic groups, especially those from Eastern Africa. Methods Between 2002 and 2012 we conducted a population-based cohort study among residents of Ontario, Canada. We used administrative health databases that linked immigrants and Canadian-born individuals to both prescription medication use and emergency department visits and hospital admissions. The primary composite outcome was the risk of drug overdose or all-cause mortality within 30 days of codeine prescription, comparing patients from various world regions to Canadian-born individuals. A secondary analysis stratified by codeine dose and ability to speak English and/or French. Results There were 553 504 individuals exclusively prescribed codeine. Relative to an incidence rate of 57.1/ 100000 person-days among Canadian-born codeine recipients, those who migrated from various world regions were at a lower risk of drug overdose or death. For example, Eastern Africans had an adjusted HR of 0.60 (95% CI 0.31 to 1.17) on controlling for potential confounders such as age, sex, income and physician visits. Patients unable to speak English or French who were prescribed codeine were at a lower risk of the composite outcome relative to those proficient in either language (adjusted HR 0.63, 95% CI 0.54 to 0.74). Interpretation Overdose and death following the institution of codeine therapy are not more commonly observed among immigrants from world regions with a high prevalence of ultrarapid CYP2D6 status relative to those born in Canada. Lower proficiency in English or French also did not appear to heighten the risk.
机译:背景技术移民可能会有较高的药物不良反应风险,因为较差的语言能力会降低个人对药物标签说明的理解。另外,在某些种族中,特别是来自东部非洲的种族中,有报告称由于CYP2D6超快性可待因向吗啡的肝代谢会导致严重或致命的毒性。方法在2002年至2012年之间,我们对加拿大安大略省的居民进行了基于人群的队列研究。我们使用了行政健康数据库,该数据库将移民和加拿大出生的个人与处方药的使用以及急诊就诊和入院联系起来。主要的综合结果是可待因处方后30天内药物过量或全因死亡的风险,将世界各地的患者与加拿大出生的个体进行了比较。二级分析按可待因剂量和说英语和/或法语的能力进行分层。结果共有553 504个人专门服用可待因。相对于加拿大出生的可待因接受者的发病率为57.1 / 100000人日,从世界各个地区迁徙的人吸毒或死亡的风险较低。例如,东部非洲人在控制年龄,性别,收入和就医机会等潜在混杂因素时,调整后的HR为0.60(95%CI为0.31至1.17)。与那些精通这两种语言的患者相比,开了可待因处方但不能说英语或法语的患者综合结局的风险较低(HR调整为0.63,95%CI为0.54至0.74)。解释在可待因治疗后,服用过量可可因和死亡的情况在来自世界各地的移民中并不普遍,相对于加拿大出生的移民,这些地区的超快CYP2D6地位较高。英语或法语水平较低似乎也没有增加风险。

著录项

  • 来源
    《Journal of Epidemiology & Community Health 》 |2014年第11期| 1057-1063| 共7页
  • 作者单位

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada,Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada,Department of Medicine, St. Michael's Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada,Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada,Department of Medicine, University of Toronto, Toronto, Ontario, Canada,Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada,Department of Medicine, University of Toronto, Toronto, Ontario, Canada,Keenan Research Centre, Li Ka Shing Knowledge Institute, St. Michael's Hospital, Toronto, Ontario, Canada;

    Institute for Clinical Evaluative Sciences, University of Toronto, Toronto, Ontario, Canada,Department of Medicine, University of Toronto, Toronto, Ontario, Canada;

  • 收录信息 美国《科学引文索引》(SCI);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号